Lipid Controls
Apexbio Technology LLC DMG-PEG2000-N3 50mg
DMG-PEG2000-N3 is a PEGylated lipid derivative utilized for the functionalization of lipid-based drug delivery systems It consists of 1 2-dimyristoyl-sn-glycerol (DMG) polyethylene glycol (PEG 2000 Da) and a terminal azide group (N3) The azide functional group enables selective conjugation via copper-catalyzed azide-alkyne cycloaddition (CuAAC or click chemistry) allowing controlled attachment of biomolecules small-molecule drugs fluorescent probes or targeting ligands onto lipid bilayers DMG-PEG2000-N3 is widely applied in the development of liposomal or nanoparticle formulations for targeted drug delivery and imaging in biomedical research
Medchemexpress LLC HY-112758 10mg Medchemexpress, DLin-KC2-DMA CAS:1190197-97-7 Purity:>98%
Medchemexpress, HY-112758 10mg DLin-KC2-DMA CAS:1190197-97-7 DLin-KC2-DMA is a cationic/ionizable lipid for siRNA delivery. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Apexbio Technology LLC DSG-PEG 2000 250mg
DSG-PEG 2000 is a PEG-modified lipid that can be used with cationic lipids such as D-Lin-MC3-DMA (No A8791) to prepare cationic nanoparticles (LNP) capable of encapsulating and delivering siRNA mRNA DNA or small molecules into the cytoplasm
Medchemexpress LLC DLin-KC2-DMA | 1190197-97-7 | ≥98.0% | 642.09 | 25 MG
DLin-KC2-DMA is an ionizable cationic lipid (pKa≈6) that is virtually non-toxic to antigen presenting cells (APCs). It produces significant siRNA-mediated gene silencing of GAPDH when bound to lipid nanoparticles (LNP). DLin-KC2-DMA can be used in siRNA delivery studies.
- Ionizable cationic lipid (pKa≈6).
- Virtually non-toxic to antigen presenting cells (APCs).
- Produces significant siRNA-mediated gene silencing of GAPDH when bound to lipid nanoparticles (LNP).
- Can be used in siRNA delivery studies.
- High uptake into macrophages and dendritic cells.
- Efficiently promotes release of encapsulated siRNA into the cytosol following uptake via the endocytotic pathway.
- Displays almost no toxicity in primary APCs.
- Effective in silencing target genes in APCs in vivo (5 mg/kg; i.v.; single).
Cayman Chemical 1 3DIoleoyl2Octnoyl Glyce 5mg
A triacylglycerol; been used to characterize the functionality of R. oryzae lipase for regiodistribution analysis of fats containing medium- and short-chain fatty acids
![Medchemexpress LLC 3-[2,2-bis[(9Z,12Z)-octadeca-9,12-dienyl]-1,3-dioxolan-4-yl]-N,N-dimethylpropan-1-amine | 1217306-46-1 | >98.0% | C44H81NO2 | 10MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000261464.png-250.jpg)
Medchemexpress LLC 3-[2,2-bis[(9Z,12Z)-octadeca-9,12-dienyl]-1,3-dioxolan-4-yl]-N,N-dimethylpropan-1-amine | 1217306-46-1 | >98.0% | C44H81NO2 | 10MG
A synthetic cationic lipid used in the formulation of nucleic acid-lipid particles (LNPs) for research delivery of RNA and DNA. It promotes encapsulation and cellular uptake of nucleic acids when combined with helper lipids and is supplied for laboratory research use only.
- Cationic lipid for formulation of nucleic acid-lipid particles.
- Facilitates encapsulation and delivery of RNA and DNA.
- High purity suitable for research applications.
- Powder form, soluble in DMSO for preparation of stock solutions.
- Recommended storage at -20°C to maintain stability.
eMolecules BP Lipid 146 | Broadpharm |682.128 | C42H83NO5 | 0.000 | CCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCCN(CCCO)CCCCCCC(=O)OCCCCCCC | 50mg | 672542562
BP Lipid 146 | Broadpharm |682.128 | C42H83NO5 | 0.000 | CCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCCN(CCCO)CCCCCCC(=O)OCCCCCCC | 50mg | 672542562
Cayman Chemical DLIn-MC2-DMA 1mg
An ionizable cationic lipid; has been used in the formation of LNPs; LNPs containing DLin-MC2-DMA and encapsulating siRNA targeting mRNA encoding FVII reduce hepatic levels of FVII in mice (ED50 = 0.6 mg/kg)